Anna Maria Rita Redavid

I completed my Molecular and Industrial Biotechnology degree at the University of Bologna in 2015. For my thesis project, I worked at the Hematology Institute at Sant’Orsola Malpighi Hospital, focusing on Immunogenic Cell Death (ICD) induced by chemotherapy in Acute Myeloid Leukemia. After graduation, I was awarded a scholarship from the Unipharma Graduates Consortium, coordinated by La Sapienza University, which allowed me to intern at Commisariat à l’Energie Atomique (CEA) in Paris. There, I worked on a research project concerning the impact of the protein LaminB1 on telomeric instability. Subsequently, I had the opportunity to participate in the Master II program in Aging Biology, offered by a consortium of French universities (Paris-Descartes, Paris-Diderot, Versailles-St-Quentin, Paul Sabatier, and François Rabelais) in Paris. After completing the master's program, I joined Dr. Patrick Mehlen's laboratory at the Cancer Research Center of Lyon, affiliated with the University of Lyon. In 2020, I obtained a PhD in Molecular, Integrative, and Cellular Biology, focusing on characterizing the impact of Netrin-1, a protein belonging to the Laminin family and expressed by breast cancer stem cells, on myeloid-derived suppressor cells. During my doctoral studies, I secured two funding opportunities: the first from the 'Ligue contre le cancer' association to support my fourth year of PhD, and the second from the University of Lyon, which allowed me to conduct a six-month research period at the University of New York, where I studied myeloid cells in greater detail. In 2021, I moved to the Karolinska Institutet Research Center in Stockholm, where I began developing a cellular therapy based on immune cells called Natural Killer against brain tumors. In 2023, I conducted a brief research period at Bambino Gesù Pediatric Hospital in Rome, and since April 2024, I have been working in the Translational Research Laboratory of AUSL-IRCSS in Reggio Emilia. My current research focuses on studying the molecular mechanisms involved in Natural Killer cell cytotoxicity and how to enhance them to increase the immune response against breast tumors.

Researcher ID: DZI-2506-2022
ORCID iD: 0000-0002-1332-2792
Scopus author ID: 57200047746

My e-mail: annamariarita.redavid@ausl.re.it